|
Jul 25
|
Alligator Bioscience Announces Upcoming Presentation of REACtiVe-2 Phase 1 Data at ESMO Congress 2025
|
|
Feb 20
|
Alligator Bioscience Carries Out a Directed Issue of Units to Guarantors and a Directed Issue of Warrants to Fenja Capital in Connection with the Completed Rights Issue
|
|
Oct 9
|
Alligator Bioscience AB (FRA:7AL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
|
Jun 25
|
Alligator Bioscience Announces Financing of Up to SEK 80 Million Extending Cash Runway to Q1 2025
|